| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $1,999,819 ) |
| | 2025 | 2025 | STARLIGHT CARDIOVASCULAR, INC. | 9710 SCRANTON RD | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | R44HL162218 | DEVELOPMENT OF A PULMONARY FLOW RESTRICTOR FOR HYPOPLASTIC LEFT HEART SYNDROME | 001 | 3 | NIH | 5/21/2025 | $0 |
| | 2025 | 2025 | STARLIGHT CARDIOVASCULAR, INC. | 9710 SCRANTON RD | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | R44HL158304 | DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY | 000 | 4 | NIH | 12/9/2024 | $999,918 |
| | 2025 | 2025 | STARLIGHT CARDIOVASCULAR, INC. | 9710 SCRANTON RD | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | R44HL158304 | DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY | 003 | 4 | NIH | 9/10/2025 | $0 |
| | 2025 | 2025 | STARLIGHT CARDIOVASCULAR, INC. | 9710 SCRANTON RD | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | R44HL158304 | DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY | 002 | 4 | NIH | 6/4/2025 | $0 |
| | 2025 | 2025 | STARLIGHT CARDIOVASCULAR, INC. | 9710 SCRANTON RD | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | R44HL162218 | DEVELOPMENT OF A PULMONARY FLOW RESTRICTOR FOR HYPOPLASTIC LEFT HEART SYNDROME | 000 | 3 | NIH | 2/20/2025 | $999,901 |
| | 2025 | 2024 | STARLIGHT CARDIOVASCULAR, INC. | 9710 SCRANTON RD | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | SB1HL176266 | Commercialization Readiness for Ductus Arteriosus Stent to Improve Congenital Heart Defect Mortality | 000 | 1 | NIH | 8/9/2025 | $0 |
| | 2025 | 2023 | STARLIGHT CARDIOVASCULAR, INC. | 9710 SCRANTON RD | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | R44HL158304 | DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY | 001 | 3 | NIH | 5/22/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $1,588,452 ) |
| | 2024 | 2024 | STARLIGHT CARDIOVASCULAR, INC. | 9710 SCRANTON RD | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | R44HL162218 | DEVELOPMENT OF A PULMONARY FLOW RESTRICTOR FOR HYPOPLASTIC LEFT HEART SYNDROME | 001 | 2 | NIH | 6/11/2024 | $88,483 |
| | 2024 | 2024 | STARLIGHT CARDIOVASCULAR, INC. | 9710 SCRANTON RD | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | R44HL162218 | DEVELOPMENT OF A PULMONARY FLOW RESTRICTOR FOR HYPOPLASTIC LEFT HEART SYNDROME | 000 | 2 | NIH | 3/20/2024 | $999,969 |
| | 2024 | 2024 | STARLIGHT CARDIOVASCULAR, INC. | 9710 SCRANTON RD | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | SB1HL176266 | Commercialization Readiness for Ductus Arteriosus Stent to Improve Congenital Heart Defect Mortality | 000 | 1 | NIH | 9/15/2024 | $500,000 |
| | 2024 | 2022 | STARLIGHT CARDIOVASCULAR, INC. | 9710 SCRANTON RD | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | R43HL162218 | DEVELOPMENT OF A PULMONARY FLOW RESTRICTOR FOR HYPOPLASTIC LEFT HEART SYNDROME | 000 | 1 | NIH | 12/1/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $901,548 ) |
| | 2023 | 2023 | STARLIGHT CARDIOVASCULAR INC | 9710 SCRANTON RD | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | R44HL158304 | DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY | 000 | 3 | NIH | 7/14/2023 | $901,548 |
|
| Issue Date FY: 2022 ( Subtotal = $1,704,635 ) |
| | 2022 | 2022 | STARLIGHT CARDIOVASCULAR, INC. | 9710 SCRANTON RD STE 100 | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | R43HL162218 | DEVELOPMENT OF A PULMONARY FLOW RESTRICTOR FOR HYPOPLASTIC LEFT HEART SYNDROME | 000 | 1 | NIH | 2/15/2022 | $448,000 |
| | 2022 | 2022 | STARLIGHT CARDIOVASCULAR, INC. | 9710 SCRANTON RD STE 100 | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | R44HL158304 | DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY | 000 | 2 | NIH | 9/19/2022 | $1,256,635 |
| | 2022 | 2021 | STARLIGHT CARDIOVASCULAR INC | 9710 SCRANTON RD | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | R43HL158304 | DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY | 000 | 1 | NIH | 8/17/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $492,571 ) |
| | 2021 | 2021 | STARLIGHT CARDIOVASCULAR, INC. | 9710 SCRANTON RD STE 100 | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | R43HL158304 | DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY | 001 | 1 | NIH | 8/18/2021 | $0 |
| | 2021 | 2021 | STARLIGHT CARDIOVASCULAR, INC. | 9710 SCRANTON RD STE 100 | SAN DIEGO | CA | 92121-1744 | SAN DIEGO | USA | R43HL158304 | DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY | 000 | 1 | NIH | 8/6/2021 | $492,571 |
|
|
